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ABSTRAK 
KELAZIMAN KAWALAN GLISEMIK YANG BAIK DAN FAKTOR-FAKTOR 
BERKAITAN DALAM KALANGAN PESAKIT DIABETES GESTASI DI 
BACHOK, KELANTAN 
Pengenalan: Kelaziman diabetes gestasi telah menunjukkan kecenderungan 
peningkatan dari tahun ke tahun. Diabetes gestasi adalah keadaan perubatan yang boleh 
dikawal dan diabetes gestasi yang tidak terkawal telah dikaitkan dengan pelbagai 
morbiditi dan mortaliti kepada ibu dan bayi. Oleh itu, adalah penting untuk memastikan 
bahawa ibu-ibu dengan diabetes gestasi mempunyai kawalan glisemik yang baik untuk 
mengelakkan kesan-kesan negatif ini. 
Objektif: Untuk menentukan kelaziman kawalan glisemik yang baik dan faktor-faktor 
yang berkaitan di kalangan pesakit diabetes gestasi yang menghadiri klinik antenatal di 
Bachok. 
Kaedah: Ini merupakan kajian keratan rentas dengan tinjauan rekod retrospektif 
sebanyak 129 pesakit diabetes gestasi yang didiagnos dari Jun sehingga November 
2014. Ciri-ciri sosio-demografi dan perubatan pesakit telah dikumpulkan dari kad 
antenatal dan direkodkan dalam borang laporan kes. Ciri-ciri perubatan yang diambil 
kira termasukah indeks jisim tubuh badan pada permulaan, umur gestasi ketika 
diagnosis diabetes gestasi, berat badan sehingga diabetes gestasi didiagnosis, tahap FBG 
dan 2HPP pada masa diagnosis, sejarah pengguguran, sejarah diabetes gestasi yang 
terdahulu dan sejarah bayi macrosomik. Kawalan glisemik yang baik ditakrifkan 
sebagai sama ada: (i) yang mempunyai sekurang-kurangnya 75% daripada bacaan profil 
gula dalam darah dalam julat normal dalam dua bacaan berturut-turut atau (ii) yang 
tidak memerlukan insulin selepas dua bacaan profil gula dalam darah berturut-turut.  
xi 
 
Data dimasukkan dan dianalisa menggunakan perisian SPSS versi 22.0. 
Keputusan: Kelaziman kawalan glisemik yang baik adalah 61.2% (95% CI, 0.53, 
0.70)(n=79). Purata (SD) umur dan pariti (SD) pesakit dalam kajian ini adalah 
31.2(6.00) dan 3.4(2.08). Regresi logistik pelbagai menunjukkan umur gestasi ketika 
diagnosis diabetes gestasi (OR= 0.93, 95% CI: 0.87, 1.00, p= 0.048), tahap FBG pada 
masa diagnosis (OR=0.28, 95% CI:0.15, 0.50, p=0.001), sejarah diabetes gestasi 
terdahulu (OR= 0.23, 95% CI: 0.06, 0.84 p= 0.026) dan sejarah bayi makrosmik (OR= 
10.45, 95% CI: 1.80, 60.69 p= 0.009) sangat berkait dengan kawalan glisemik yang 
baik. 
Kesimpulan: Kelaziman kawalan glisemik yang baik di kalangan pesakit diabetes 
gestasi dalam kajian ini adalah munasabah. Umur gestasi ketika diagnosis diabetes 
gestasi, tahap FBG ketika diagnosis diabetes gestasi, kehadiran sejarah diabetes gestasi 
terdahulu dan ketiadaan sejarah bayi makrosmik dikaitkan dengan kawalan glisemik 
yang baik. 
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ABSTRACT 
PREVALENCE OF GOOD GLYCAEMIC CONTROL AND ITS ASSOCIATED 
FACTORS AMONG GESTATIONAL DIABETES PATIENTS IN BACHOK, 
KELANTAN 
Introduction: The prevalence of GDM has shown an increasing trend from year to 
year. GDM can be effectively controlled and uncontrolled GDM had been associated 
with a wide range of morbidities and mortalities to mothers and infants. Hence, it is 
important to ensure that mothers with GDM have good glycaemic control in order to 
prevent these negative outcomes. 
Objectives: To determine the prevalence of good glycaemic control and its associated 
factors among GDM patients attending antenatal clinic in Bachok. 
Methodology: This is a cross sectional study with retrospective record review of 129 
GDM patients who were diagnosed from June to November 2014 The socio-
demographic and medical characteristics of patients were gathered from the antenatal 
cards and recorded in the case report form. The medical characteristics of interest 
includes BMI at booking, gestational age when GDM was diagnosed, weight gain until 
GDM was diagnosed, level of FBG and 2HPP at diagnosis, abortion history, previous 
history of GDM and history of macrosomic baby. Good Glycaemic Control was defined 
as either: (i)  having at least 75% of the blood sugar profile (BSP) readings within the 
normal range in two consecutive BSP readings or (ii) those who do not require insulin 
after two consecutive blood sugar profile (BSP) readings. Data was entered and 
analysed using SPSS version 22.0.  
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Results: The prevalence of good glycaemic control was 61.2% (95% CI, 0.53, 0.70) (n 
=79). The mean (SD) age and parity (SD) of patients in this study were 31.2(6.00) and 
3.4(2.08) respectively. Multiple logistic regression showed that gestational age at GDM 
diagnosis (OR= 0.93, 95% CI: 0.87, 1.00, p= 0.048), level of FBG at GDM diagnosis 
(OR= 0.28, 95% CI: 0.15, 0.50, p= 0.001), previous history of GDM (OR= 0.23, 95% 
CI: 0.06, 0.84 p= 0.026) and history of macrosomic baby (OR= 10.45, 95% CI: 1.80, 
60.69 p= 0.009) were significantly associated with good glycaemic control. 
Conclusion: The prevalence of good glycaemic control among GDM patients in this 
study was acceptable. Gestational age at GDM diagnosis, level of FBG at GDM 
diagnosis, presence of previous GDM history and no history of macrosomic baby were 
associated with good glycaemic control of GDM.  
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CHAPTER 1: INTRODUCTION 
Gestational diabetes mellitus (GDM) is defined as carbohydrate intolerance of variable 
severity, with first recognition of hyperglycaemia during pregnancy (WHO Guideline 
Development Group, 2013). Based on WHO 2013 guideline, GDM includes women 
with diabetes, impaired fasting glucose and impaired glucose tolerant of which the latter 
two were also referred as  intermediate hyperglycaemia. In Malaysia, screening for 
GDM is done selectively in patients with risk factors using 75g glucose at least once at 
24 to 28 weeks of gestation. However, screening should be done earlier at 16-18 weeks 
of gestation if patient has high risks (MOH, 2015). The risk factors  includes BMI more 
than 27kg/m2, previous macrosomic baby weighing 4kg or more, previous GDM, 
having first degree relative with diabetes, bad obstetric history, glycosuria  at prenatal  
visit,  current obstetric problems and age above  25 years old (MOH, 2015).  
The concern for GDM arises because uncontrolled GDM will increase morbidity and 
mortality to both fetus and mother whereas GDM is a condition that can be effectively 
controlled. GDM will increase risk of macrosomia, birth injuries such as shoulder 
dystocia, bone fracture and nerve palsies, hypoglycaemia and hyperbilirubinemia for the 
infants while for the mothers, they are at increased risk of developing pre-eclampsia and 
have an increased chance of need for induction of labour and caesarean section (Ju et 
al., 2008).  
American Diabetes Association in their latest guideline released in January 2017,  
suggested that medical nutritional therapy (MNT), physical activity and weight 
management should be started first in the treatment of GDM. However, 
pharmacological therapy should be initiated in women with greater degree of 
hyperglycaemia (American Diabetes Association, 2017). 
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1.1 Justification of study 
It was estimated that the prevalence of diabetes mellitus was 17.5% nationwide and 
Kelantan contributed 18.5% (National Health and Morbidity Survey, 2015).  This 
prevalence had been significantly raised from year to year (National Health and 
Morbidity Survey, 2015). The increment in the prevalence is worrying since it is a 
known fact that GDM is a risk factor for the development of DM type 2 later in life 
(American Diabetes Association, 2017). Thus, identifying the women with GDM early 
in their pregnancy and treat them accordingly is crucial to intercept the development of 
diabetes mellitus. Unfortunately, the data on GDM and the level of control once it had 
been diagnosed is sparse. Local studies had shown various data of prevalence of GDM 
in Malaysia. An earlier study in 2007 quote the prevalence to be 11.4% (Tan et al., 
2007) but in 2009 another study quote it to be 18.4% (Idris et al., 2009). However, a 
more recent study in  2013 quoted that prevalence of GDM is 5.2% (Kampan et al., 
2013). These studies were however small scale studies, and the prevalence was based on 
their population. Hence, the true prevalence of GDM in Malaysia is still not known.  
Nevertheless, what is more important is to estimate the number of GDM women who 
has good glycaemic control once they are diagnosed with the disease to ensure 
prevention of the unwanted sequelae. Therefore, this study aimed to determine the 
prevalence of good glycaemic control among GDM patients as well as the factors 
associated with it.  
This information will assist the health care workers in their patient’s evaluation, 
treatment planning and rationalized the health care planning. In return, it will facilitate 
the health care team in optimising the utilising of time, human and economic resources. 
Furthermore, it may guide the health care workers in planning more appropriate short-
term and long-term goals for GDM patients. 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Prevalence of GDM 
The prevalence of DM in Malaysia has shown an increasing trend over the years from 
6.3% in 1986 to 17.5% in 2015 (National Health and Morbidity Survey, 2015). 
According to American Diabetes Association, women with a history of GDM have 
greatly increased risk of conversion to type 2 diabetes over time (American Diabetes 
Association, 2017). It is estimated that about 35-60 % of women with history of GDM 
will develop type 2 diabetes mellitus within 10 years (Metzger et al., 2007). Although 
the increasing in DM prevalence in Malaysia had been well recorded, the trend for 
GDM cannot be ascertained. In Europe, the prevalence of GDM mostly figures from 2 
to 6 % while in Northern or Atlantic seaboard parts a lower prevalence at mostly less 
than 4% was reported. A higher prevalence of GDM was reported in South and 
Mediterranean seaboard at more than 6% (Buckley et al., 2012). On the other hand, the 
prevalence of GDM in Asian continent showed higher prevalence. In Qatar, the 
prevalence of GDM was 16.3 % (Bener et al., 2011) while in India the prevalence was 
18.9 % (Seshiah et al., 2004). As mentioned before, studies in Malaysia had reported 
various figures depending on their population (Tan et al., 2007; Idris et al., 2009; 
Kampan et al., 2013). There is still the need for national study to ascertain the true 
prevalence of GDM among women in Malaysia.  
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2.2 Screening of GDM 
Issues related to GDM screening had never been solved for years. Different countries 
and organizations have their own guidelines and distinctive methods in diagnosing 
GDM. Universal screening or selective screening based on the risk factors remained 
debatable. The most popular method for universal screening is 50g glucose challenge 
test (GCT). However it was reported that the glucose challenge test (GCT) is  no longer 
part of diagnostic algorithm due to lacks sensitivity and specificity (Nankervis A et al., 
2013). A local study has recommended for universal screening over risk-based 
screening method in view of better predictive value in detecting GDM (Idris et al., 
2009). Selective screening based on the risk factors was thought not to be as cost 
effective as universal screening in a population with low risk of GDM. The 
International Federation of Gynaecology and Obstetrics (FIGO) Initiative on gestational 
diabetes mellitus in their guideline recommended for universal screening rather than 
risk factor based testing in order to include all pregnant women to be tested for 
hyperglycaemia in pregnancy (Hod et al., 2015). They argued that the screening based 
approach has poor sensitivity for detection of GDM.  
On the other hand, the National Institute for Health and Care Excellent (NICE) 
recommended that GDM should be screened with 75g oral glucose tolerance test 
(OGTT) in women with risk factors (NICE, 2015). The risks that are mentioned in the 
guideline are BMI above 30kg/m
2
, previous macrosomic baby weighing 4.5kg or more, 
previous GDM, first degree family history of DM and minority ethnic family origin 
with a high prevalence of diabetes. They also suggested that the screening should be 
done at 24-28weeks of pregnancy or earlier in patient with previous history of GDM. 
The GDM can be diagnosed if the woman has either fasting plasma glucose of 
5.6mmol/l or above or 2 hour plasma glucose of 7.8mmol/l or above. Another body, 
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The Australasian Diabetes in Pregnancy Society (ADIPS) recommended women not 
known to have pre‐existing glucose abnormalities, but with risk factors for GDM which 
further classified into moderate and high risk group should be tested early in pregnancy. 
Although it is recommended in the Malaysian guideline that screening for GDM should 
be done to all pregnant women with OGTT at 24-28 week of gestation due to high 
prevalence of DM type 2 in Malaysia, but taking into consideration of some limitation 
in resources, screening only be done to high risk group of pregnant women at booking 
and then should be repeated after 4 to 6 weeks if initial screening was normal (MOH, 
2015). 
 
2.3 Glycaemic control of GDM. 
For the time being, there is no specific definition of controlled GDM. The definition of 
glycaemic control of GDM is also different in different parts of the world. The need for 
insulin therapy has been used repeatedly to indicate glycaemic control. Two studies in 
Germany and Turkey described good glycaemic control if patients were not converted 
to insulin therapy after receiving medical nutritional therapy (Schaefer-Graf et al., 2003; 
Bakiner et al., 2013). Bakiner et al in their study mentioned that the prevalence of GDM 
patients who were able to maintain optimum glycaemic control with medical nutritional 
therapy alone was 63.3% compared with 36.7% who needed antenatal insulin therapy 
(Bakiner et al., 2013). In Germany, about 93.5% of GDM patients studied had good 
glycaemic control within therapeutic threshold (Schaefer-Graf et al., 2003).  
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A more recent study in Turkey in 2015 found that about 65.2% of GDM patients were 
able to maintain good glycaemic control with diet therapy while another 34.8% were 
converted to insulin therapy after 15 days trial of diet therapy (Aktun et al., 2015). The 
definition of good glycaemic control of GDM in the study by Aktun et al was the same 
with an earlier study by Bakiner et al. 
One study done in India revealed that 90% of GDM patients have good glycaemic 
control and only 10% of them required antenatal insulin after failed medical nutritional 
therapy. The insulin was initiated after 2 weeks trial of medical nutritional therapy if 
more than 30% of glucose level measurements were above the recommended values 
(Mitra et al., 2014). In USA, one study mentioned that 74.8% of GDM patients were 
able to maintain good glycaemic control with diet and exercise whereas 25.2% required 
insulin therapy which indicates of poor glycaemic control. In that study, patients were 
instructed to perform daily fasting blood glucose with postprandial glucose and insulin 
was prescribed by the physician depends on the blood glucose level (Tudela et al., 
2006). Meanwhile in Japan, a retrospective study which enrolled GDM patients between 
2010 and 2016 found that 73% of them were able to maintain good glycaemic control 
with diet therapy while 27% were added insulin where it was started if three times of 
more of self-monitoring of blood glucose (SMBG) readings were not within target 
(Watanabe et al., 2016).  
In Netherland, a retrospective study showed about 56.1% of GDM patients from 2011 
until 2014 were able to achieve good glycaemic control. In that study, the definition of 
good glycaemic control was made if patients were able to maintain SMBG levels within 
targets with diet therapy however the insulin therapy was commenced if two elevated 
blood glucose levels were found on two successive days (Koning et al., 2016). 
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Meanwhile, a study in Brazil defined poor glycaemic control if more than 30% of the 
glucose measurements were above the recommended value or in which 20% or more of 
the measurements indicated hyperglycaemia and fetal weight was above the 75th 
percentile (Sapienza et al., 2010). In the study by Sapienza et al, 39.8% of GDM 
patients were determined to have poor glycaemic control where they were initiated with 
insulin therapy based on their blood glucose measurements to achieve desired 
glycaemic control (Sapienza et al., 2010).  
It has been suggested that the control is based on the target range acceptable for women 
with diabetes. Since a more tight control is required, women with diabetes in pregnancy 
are required to monitor their blood sugar at fasting and before each meal as well as 
before bedtime. The ideal fasting or pre-prandial reading is set to be equal or less than 
5.3mmol/l and pre-bed reading (2 hours post prandial) is set to be equal or less than 
6.7mmol/l (MOH, 2015). If desired blood glucose levels are not met after 1-2 weeks of 
diet and exercise therapy, insulin therapy should be considered to achieve optimum 
glycaemic control (MOH, 2015). Based on NICE guidelines in 2015, pregnant women 
with any form of diabetes are advised to maintain their capillary blood sugar reading 
below the target levels; fasting: 5.3mmol/L, 1-hour post prandial: 7.8mmol/L or 2-hour 
post prandial: 6.4 mmol/L (NICE, 2015). 
Role of Hba1c in measuring glycaemic control among GDM patients has little benefit. 
American Diabetes Association (ADA) in their latest guidelines in 2017 mentioned that 
HbA1c is used as a secondary measure of glycaemic control after self monitoring of 
blood glucose (American Diabetes Association, 2017). This is because Hba1c level falls 
during normal pregnancy due to the physiological increases in red blood cell turnover 
and the inability of Hba1c to fully capture postprandial hyperglycaemia (American 
Diabetes Association, 2017). National Institute for Health and Care Excellence (NICE) 
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had also suggested that Hba1c should be done to determine the level of risk to the 
pregnancy only in women with pre-existing diabetes at booking appointment and during 
second and third trimester (NICE, 2015). 
 
2.4 Factors Associated with Glycaemic Control 
Various publications and studies showed some factors predicting the glycaemic control 
of GDM (Tudela et al., 2006; Akinci et al., 2008; Sapienza et al., 2010; Tania Pertot et 
al., 2011; Wong and Jalaludin, 2011; Bakiner et al., 2013; Mitra et al., 2014; Aktun et 
al., 2015; Barnes et al., 2016; Koning et al., 2016; Watanabe et al., 2016). The 
predictors in their study were based on the existing risk factors of GDM which 
incorporated medical and socio-demographic profile of the patients. These studies 
determined the predictors for the need of insulin therapy among GDM patients which  
indirectly indicate poor glycaemic control. One study in Turkey classified the existing 
risk factors into pre-gestational (family history of DM, previous history of GDM, parity, 
abortion history and previous history of macrosomic baby), and gestational (BMI, 
gestational age at diagnosis, weight gain until diagnosis, maternal age, level of fasting 
blood glucose and level of 2 hours post prandial glucose during OGTT) (Bakiner et al., 
2013) . On the other hand, a study done in India showed the socio-economic 
background and educational status of the pregnant lady play a role in the development 
of GDM but did not study further on glycaemic control of their subjects (Rajput et al., 
2013). 
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2.4.1 Socio-demographic Factors Associated with GDM and Glycaemic Control. 
Women with age of more than 40 years old is considered to be in high risk group for 
GDM (Nankervis A et al., 2013). A study in Gaza by Zaki et al did not find any 
significant association between maternal age and developing GDM (Zaki et al., 2013). 
However a study in Pakistan reported maternal age as a risk factor for GDM (Khan et 
al., 2013). That study was on the same line with another study in India (Rajput et al., 
2013). When considering age as factor for predicting the glycaemic control, one study 
reported maternal age as a predictor for the need of insulin therapy. In this study, age 
was found to be a significant predictor for the need of insulin therapy where insulin was 
initiated if GDM patients were not able to maintain optimum glycaemic control by 
medical diet therapy after 15 days (Aktun et al., 2015). 
Gravidity and parity were thought to be risk factor for development of GDM.  Rajput et 
al reported that women with gravida 3 and more had significantly higher prevalence of 
GDM compared to gravida less than 3 (Rajput et al., 2014). However a study in Gaza 
did not find significant correlation between an increase in parity and an increase in the 
number of pregnancies with GDM (Zaki et al., 2013). On the other hand, Anna et al 
reported that parity was associated with GDM (Anna et al., 2008). In one study in 
Netherland, parity was determined to be a significant predictor for glycaemic control 
(Koning et al., 2016). In that study, parity of 1 to 2 was determined as one of the 
predictors for the need of insulin therapy after failed medical nutritional therapy in order 
to achieve optimum glycaemic control. However, another predictive study for the need 
of insulin therapy among GDM patients in Brazil which include nulliparity in the study 
did not find any significant finding (Sapienza et al., 2010). That study was supported by 
other two studies in Turkey where parity was not found to be a predictor for glycaemic 
control (Bakiner et al., 2013; Aktun et al., 2015). 
10 
 
Family history of DM is a known risk factor for development of GDM. Rajput et al in 
their study found that there was a significantly higher percentage of women with GDM 
who had positive family history of DM (Rajput et al., 2013). Few predictive studies 
reported family history as a predictor for glycaemic control. One study in Netherland in 
2016 reported family history of diabetes was a predictor for need of insulin therapy to 
maintain good glycaemic control (Koning et al., 2016). This study was supported by 
other predictive studies with similar finding  (Sapienza et al., 2010; Mitra et al., 2014). 
Sapienza et al reported that family history of diabetes was the predictor for the need of 
insulin therapy among GDM patients in order to achieve optimum glycaemic control 
after failed diet therapy (Sapienza et al., 2010). Mitra et al  in 2014 also concluded in 
their study that family history of diabetes was a predictor for antenatal need of insulin in 
which it was commenced if the blood sugar readings were above the recommended 
values (Mitra et al., 2014).   
A study in Gaza in 2013 showed that GDM was twice as high in illiterate when 
compared to non GDM pregnant ladies and there was no significant difference between 
women with GDM and the non GDM group  regarding place of residency (Zaki et al., 
2013). Meanwhile, a study by Rajput et al in 2013 in India revealed that GDM rate 
increased with increasing educational qualification and the prevalence  of GDM was 
found to be higher in women belonging to upper and upper middle class  (Rajput et al., 
2013). The socioeconomic status in the study was based on Kuppusamy’scale where it 
comprised of education, occupation and monthly income score. 
However,  a study by Bener et al in Qatar showed there was no significant difference in 
the level of education and occupation between GDM and non GDM groups but most of 
GDM patients were from lower economic group (Bener et al., 2011).  Another study in 
Australia supported the similar statement where it concluded that women living in the 
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lowest socioeconomic postcodes had two-thirds higher risk of developing GDM 
compared with women in the highest group (Anna et al., 2008). The socioeconomic 
status in the study was assigned according to the maternal postcode using the index of 
advantage/disadvantage from the Australian Bureau of Statistics Socio-Economic 
Indexes for Areas (SEIFA). A more recent study in Pakistan in 2013 showed  there was 
no difference in term of monthly income, female occupation and education level 
between GDM and healthy pregnant women (Khan et al., 2013).  
 
2.4.2 Medical Characteristics Associated with GDM and Glycaemic Control. 
Obesity is one of risk factors for developing of GDM. Hence, various guidelines 
suggested women with high BMI should be screened for GDM (Nankervis A et al., 
2013; MOH, 2015; NICE, 2015). This was supported by various studies where there 
was significant association between prevalence of GDM and increasing BMI (Bener et 
al., 2011; Khan et al., 2013; Rajput et al., 2013; Zaki et al., 2013). There were also 
various predictive studies that reported pre-pregnancy BMI as a predictor for need of 
insulin therapy in order to achieve better glycaemic control (Sapienza et al., 2010; Tania 
Pertot et al., 2011; Wong and Jalaludin, 2011; Barnes et al., 2016; Koning et al., 2016). 
Koning et al reported that pre-pregnancy BMI of more than 30kg/m2 was a significant 
predictor for insulin need to achieve good glycaemic control (Koning et al., 2016). That  
study was on the same line with other studies which reported BMI more than 30kg/m2 
as a predictor for insulin need among GDM patients after failed medical nutritional 
therapy in order to achieve optimum glycaemic control (Sapienza et al., 2010; Wong 
and Jalaludin, 2011).  
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Tudela et al in their study reported that gestational age at diagnosis was a predictor for 
need of insulin therapy to achieve good glycaemic control (Tudela et al., 2006). In this 
study, gestational age at GDM diagnosis which less than 28 weeks was determined to be 
a predictor for need of insulin therapy. That study was supported by another study in 
Australia where it was reported that gestational age at diagnosis of GDM was a 
predictor for undesirable glycaemic control where insulin was added to those who failed 
to maintain good glycaemic control with medical nutritional therapy (Wong and 
Jalaludin, 2011). 
Rajput et al reported that women with GDM had higher weight gain compared to non-
GDM women (Rajput et al., 2013). GDM mothers who were on diet therapy had a more 
significant weight gain compared to insulin group but this factor was not a predictor for 
need of insulin therapy to achieve better glycaemic control (Koning et al., 2016). Other 
studies which reported the similar finding with this study were Bakiner et al and Aktun 
et al. (Bakiner et al., 2013; Aktun et al., 2015). 
Various predictive studies reported oral glucose tolerance test (OGTT) readings as the 
predictor for glycaemic control. A study in Netherland which studied on predictors of 
poor glycaemic control among GDM patients reported that both fasting and 2-hour post- 
prandial in the OGTT reading were predictors for the need of insulin therapy to achieve 
glycaemic control (Koning et al., 2016). This was similar to finding by Wong and 
Jalaludin in Australia (Wong and Jalaludin, 2011). Akinci et al supported this finding 
through their report that the level of fasting blood glucose was a significant predictor for 
insulin need in patients with GDM (Akinci et al., 2008). In that study, they found that 
68.7% of patients with fasting blood glucose level equal or higher than 95mg/dl or 
5.3mmol/L required insulin therapy to achieve better glycaemic control. Similar finding 
were reported by Bakiner et al and Aktun et al (Bakiner et al., 2013; Aktun et al., 
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2015). In addition, Watanabe et al  in 2016 reported that the level of 1-hour post 
prandial blood glucose level in OGTT during diagnosis of GDM was also the predictor 
for insulin therapy to achieve better glycaemic control (Watanabe et al., 2016).A study 
by Idris et al  had included history of recurrent miscarriage as a risk factor for a 
pregnant lady to be screened for GDM (Idris et al., 2009). This was seconded by a few 
other studies which reported that women with history of miscarriage (more than once) 
were at higher risk for developing GDM (N. Wah Cheung et al., 2001; Bener et al., 
2011; Zaki et al., 2013).  
Women with previous history of GDM were advised to test for GDM as soon as 
possible after booking and further at 24- 28 weeks if the first test was normal (NICE, 
2015). This is because studies had demonstrated that previous history of GDM is a 
strong predictor for development of GDM on next pregnancy (Bhat et al., 2010; Rajput 
et al., 2013). However, there were mixed findings in the previous studies about the 
previous history of GDM as a predictor for glycaemic control of GDM. Koning et al  in 
their study concluded that previous history of GDM was a predictor for glycaemic 
control where glycaemic control was portrayed by the need of insulin therapy to achieve 
good control of GDM (Koning et al., 2016). On the contrary, Sapienza et al in their 
study found that previous history of GDM was not a predictor to insulin treatment in 
order to achieve good glycaemic control (Sapienza et al., 2010). Similar finding were 
noted in other studies where previous history of GDM was not determined as predictor 
for glycaemic control (Tudela et al., 2006; Bakiner et al., 2013; Aktun et al., 2015; 
Watanabe et al., 2016).  
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Previous history of macrosomic baby is an established risk factor for developing of 
GDM in various guidelines (Nankervis A et al., 2013; MOH, 2015; NICE, 2015). 
Various studies reported that the history of macrosomic baby was found to have an 
independent association with prevalence of GDM (N. Wah Cheung et al., 2001; Bener 
et al., 2011; Zaki et al., 2013; Rajput et al., 2014). A study by Koning et al 
demonstrated that  previous history of macrosomic baby of more than 4.5kg was a 
predictor for glycaemic control (Koning et al., 2016). In that study, previous history of 
macrosomic baby was determined to be a predictor for insulin therapy in which patients 
who were unable to achieve optimum blood glucose levels were added insulin therapies.  
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Figure 1 Conceptual Framework
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CHAPTER 3 : OBJECTIVES 
3.1 General Objective 
To determine the prevalence of good glycaemic control and its associated factors among 
GDM patients attending antenatal clinic in Klinik Kesihatan in Bachok. 
3.2 Specific Objectives : 
1. To determine the prevalence of good glycaemic control among GDM patients 
attending antenatal clinic in Klinik Kesihatan in Bachok. 
2. To determine the associated factors for good glycaemic control among GDM patients 
attending antenatal clinic in Klinik Kesihatan in Bachok. 
3.3 Operational Definition: 
Gestational Diabetes Mellitus (GDM) is a type of diabetes mellitus that is first 
recognized during pregnancy using oral glucose tolerance test (OGTT) of 75g 
anhydrous glucose. It is diagnosed if fasting blood glucose level is equal or more than 
5.6 mmol/l or postprandial glucose is equal or more than 7.8mmol/l (WHO Guideline 
Development Group, 2013) 
Good Glycaemic Control is defined as either: (i)GDM patients in whom at least 75% of 
the blood sugar profile (BSP) readings are within the normal range as stated in the 
Malaysian guideline (MOH, 2015) in two consecutive BSP readings after dietary 
advice. The normal limit for pre-breakfast and pre-prandial is equal to 5.3 or less and 
for two hours post prandial (pre-bed) reading is equal to 6.7 or less (MOH, 2015), or 
(ii)GDM patients who are not requiring insulin after two consecutive blood sugar 
profile (BSP) readings. 
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3.4 Hypothesis 
Socio-demographic (age, parity, education level and family history of diabetes) and 
medical characteristics of GDM patients (BMI at booking, gestational age at diagnosis 
of GDM, weight gain until diagnosis of GDM, level of FBG and 2HPP at diagnosis of 
GDM, abortion history, previous history of GDM and history of macrosomic baby) are 
significant factors associated with good glycaemic control in gestational diabetes 
mellitus patients. 
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CHAPTER 4: METHODOLOGY 
4.1 Study Design 
This is a cross-sectional study with a retrospective record review.  
4.2 Study Area 
This study was conducted in Bachok district involving all Klinik Kesihatan. The district 
of Bachok is one of 10 districts in Kelantan. Bachok is among the district which has 
high rate of GDM in Kelantan. Based on 2014 local unpublished data from Bachok 
health district office, the proportion of GDM among new antenatal cases was 14.9%. 
Bachok has eight Klinik Kesihatan which are Klinik Kesihatan Bachok, Klinik 
Kesihatan Balai, Klinik Kesihatan Beris Panchor, Klinik Kesihatan Beris Kubur Besar, 
Klinik Kesihatan Mahligai, Klinik Kesihatan Gunong, Klinik Kesihatan Kuchelong and 
Klinik  Kesihatan Kandis. All health clinics provide antenatal service with varies 
patients’ attendance based on their population coverage. 
4.3 Study period/duration. 
This study period was from June to November 2015. 
4.4 Reference population 
The reference population was all GDM patients in Bachok district. 
4.5 Source population 
All GDM mothers attending antenatal clinic in Klinik Kesihatan in Bachok, Kelantan 
4.6 Study sample 
The study sample was all GDM mothers attended antenatal clinic in Klinik Kesihatan in 
Bachok who fulfilled the inclusion and exclusion criteria. 
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4.7 Inclusion Criteria 
GDM mothers with at least two consecutive blood sugar profiles reading after dietary 
advice given by nutritionist. 
4.8 Exclusion Criteria 
Patients with established type 1 or type 2 diabetes mellitus. 
4.9 Sampling Method 
Universal sampling method was used in this study due to the limited samples within the 
given time period. 
4.10 Sample Size Calculation 
4.10.1 Sample size determination for objective 1. 
Sample size to determine the prevalence of good glycaemic control among GDM 
patients was calculated based on single proportion formula (Daniel, 2005). 
n =    Z α/2 
2   
P(1-P) 
           
n = Minimum required sample size 
Zα/2 = Value of standard normal distribution was 1.96 
 = Precision of 0.05 
p = proportion of good glycaemic control = 93.5% (Schaefer-Graf et al., 2003) 
The proportion of good glycaemic control was 93.5% (Schaefer-Graf et al., 2003) and 
taking the precision of 0.05 with 95% confidence, the minimum required sample size 
was 94. After considering a non-response rate of 10%, the calculated sample size was 
103 antenatal cards. 
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4.10.2 Sample size determination for objective 2  
Sample size was calculated using PS-Power and sample size calculation. Sample to 
identify the associated factors for good glycaemic control among GDM patients are 
based on comparing two proportions for categorical variables and comparing two means 
for numerical variables (Appendix B). The variable that yielded the biggest sample size 
for this objective was that of previous history of GDM. 
α = 0.05 
power = 0.8 
P0 = proportion of history of GDM among poor control = 29.0% (Bakiner et al., 2013) 
P1 = proportion of history of GDM among good control = 9% (Expert opinion) 
m = ratio of poor control to good control GDM  = 1 
The proportion of previous history of GDM among poor control was 0.29 (Bakiner et 
al., 2013) and the minimum required sample size was 118. After considering the non-
response rate of 10%, the calculated sample size for each group of cases and controls 
was 129.  
The biggest sample size was from Objective 2 (n = 129) and was taken as the study 
sample. 
 
4.11 Research Tool 
The case report form (Appendix A) obtained responses on sociodemographic and 
medical data, namely, maternal age, parity, level of education, family history of DM, 
previous history of GDM, previous macrosomic baby, abortion history, BMI at booking, 
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weight gain until GDM diagnosis, gestational age at diagnosis of GDM, level of fasting 
blood glucose at diagnosis, level of 2 hours post prandial at diagnosis, date of receiving 
dietary advice and level of blood sugar profile monitoring. 
 
4.12 Data Collection 
All antenatal cards of GDM mothers diagnosed from June 2014 until November 2014 in 
Bachok district were collected. The antenatal cards were then reviewed in accordance to 
each health clinic visits. The socio-demographic and medical characteristics from a 
copy of antenatal card (Rekod Kesihatan Ibu KIK/ 1(b) /96) were obtained (Figure 2).  
 
4.13 Data Entry and  Statistical Analysis 
All collected data were entered, cleaned and analysed using the SPSS software version 
22. Data checking and cleaning were performed before analysis. The distributions and 
frequencies of variables were examined. Categorical variables were described in 
frequencies and percentage. Small cell categories were identified and collapsed 
accordingly. Categories with small sample size were identified and meaningful 
combinations of categories were done when indicated. 
Descriptive analysis was performed to calculate the prevalence of good glycaemic 
control of GDM and each variable. Simple and multiple logistic regression analyses 
were performed to identify the factors associated with good glycaemic control of GDM. 
The dependent variable was glycaemic control (0 = Poor glycaemic control, 1 = good 
glycaemic control). The independent numerical variables in this study which were age, 
parity, BMI at booking, gestational age at diagnosis of GDM, weight gain until 
diagnosis of GDM, level of FBG and 2HPP at diagnosis were described as mean and 
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standard deviation (SD) for normally distributed data and median and inter quartile 
range (IQR) for not normally distributed data. The independent categorical variables 
which were education level, family history of diabetes, abortion history, previous 
history of GDM and history of macrosomic baby. 
The numerical variables were defined as follows. Parity is defined as the number of 
times that a woman has given birth to a fetus with a gestational age of 24 weeks or 
more, regardless of whether the child was born alive or was stillborn. Body Mass Index 
(BMI) at booking is defined as BMI at the time of first antenatal visit and was 
calculated with the formula of (weight(kg)/Height(m)
2
). Weight gain until GDM 
diagnosis is defined as amount of weight gained in kilogram by a patient from her first 
antenatal visit until diagnosis of GDM. Gestational age at diagnosis of GDM is defined 
as gestational age (expressed in week) of patient at the time of diagnosis of GDM. Level 
of fasting blood glucose at diagnosis is defined as the level of fasting blood glucose 
(expressed in mmol/l) in Oral Glucose Tolerance Test (OGTT) during diagnosis of 
GDM. Level of 2 hours postprandial at diagnosis is defined as the level of blood 
glucose after 2 hours of 75g anhydrous glucose ingestion (expressed in mmol/l) in Oral 
Glucose Tolerance Test (OGTT) during diagnosis of GDM. 
The categorical variables were defined as follows. Level of education is categorised into 
(i) Lower education level (Primary school and Secondary school) and (ii) Upper 
education level (Diploma / Degree / Postgraduate level). Family history of Diabetes 
Mellitus is categorised into (i) presence of family history of diabetes among first degree 
family member or siblings, and (ii) absence. Previous history of GDM is categorised 
into (i) presence of history of being diagnosed of GDM in previous pregnancy and (ii) 
absence. Previous macrosomic baby is categorised into (i) history of giving birth 4kg 
and more in previous pregnancy and (ii) absence. 
23 
 
The procedure of simple and multiple logistic regression analyses 
Simple logistic regression, was used as a screening in the selection of variables.  All 
variables with p value less than 0.25 and clinically significant variables were included 
in multiple logistic regression. The p value was set larger than the level of significance 
to allow more important variables in the model. Multiple logistic regression using 
backward LR method was applied in this analysis. The preliminary main effect model 
was obtained. 
Multicollinearity and all possible 2 way interactions were assessed. The preliminary 
final model was obtained. Model fitness tested with Hosmer-Lemeshow test, overall 
classification percentage and area under receiver operating characteristics (ROC) curve. 
The high overall classification percentage of more than 70% and area under curve of 
more than 70% showed the model is fit. The final model was presented as Wald statistic 
(Wald stat), adjusted odds ratio (adj OR), 95% confidence interval (95% CI) and p 
value.  
 
4.14 Ethical Consideration 
Ethical approval was obtained from Human Research Ethics Committee USM 
(USM/JEPeM/14090318) on 5 March 2015 and Medical Research & Ethics Committee 
(NMRR-14-1299-22330) on 12 February 2015. Permission from Kelantan State Health 
Department and Bachok District Health Office were obtained prior to data collection. 
All collected data was kept in confidential and for the eyes of involved researchers only. 
Each patient record was identified with coded number so that the true identity of the 
patient was kept confidential 
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Figure 2 Flow chart of the study 
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